Two Sigma Investments’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-57,258
Closed -$22.3K 3459
2023
Q4
$22.3K Sell
57,258
-8,716
-13% -$6.95K ﹤0.01% 3049
2023
Q3
$106K Buy
+65,974
New +$182K ﹤0.01% 2739
2022
Q4
Sell
-34,540
Closed -$44K 3133
2022
Q3
$44K Buy
+34,540
New +$75.2K ﹤0.01% 2326
2022
Q2
Sell
-53,938
Closed -$373K 3041
2022
Q1
$373K Buy
53,938
+6,031
+13% +$63.9K ﹤0.01% 2140
2021
Q4
$762K Buy
+47,907
New +$959K ﹤0.01% 2807

Other funds holding RNLX

Two Sigma Investments's RNLX Position: Q1 2024 in Review

Two Sigma Investments sold out of Renalytix plc American Depositary Shares (RNLX) in Q1 2024, closing a stake of 57,258 shares — an estimated $22.3K sold.

Two Sigma Investments first reported a position in RNLX in Q4 2021 and held it in 5 quarters. The position peaked at $762K in Q4 2021. 26 funds tracked by Wall St. Rank hold RNLX as of Q1 2024.

  • Two Sigma Investments reported no remaining Renalytix plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 57,258 Renalytix plc American Depositary Shares shares in Q1 2024, an estimated $22.3K.
  • Two Sigma Investments first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 5 quarters.
  • Two Sigma Investments's Renalytix plc American Depositary Shares position peaked at $762K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.